Phase 4 N=80 Prevention of Atrial Fibrillation Following Esophagectomy
Atrial Fibrillation · Esophagectomy
Primary: Incidence of Atrial Fibrillation — 6; 16 participants — p=0.02
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=28 Treatment of Upper Extremity Deep-Vein Thrombosis
Deep-Vein Thrombosis
Primary: Percentage of Participants That Died at 3 Months — 8; 0 percentage of participants
Phase 4 N=39 Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Down Syndrome
Primary: Changes in Neuropsychological Measures From Baseline to End of Study — -0.22; -0.84; 0.56; 0 units on a scale — p=0.403
Phase 4 N=372 The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.
Breast Cancer
Primary: Number of Patients With Body Mass Index (BMI) Over 25 Who Developed Surgical Site Infection (SSI) in Groups Who Received Antibiotic Prophylaxis (Prophylaxis Group) and…
Phase 4 N=642 Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
Bladder Cancer · Cervical Cancer · Esophageal Cancer
Primary: 24-hour Point Prevalence Abstinence at the 6-month Follow up — 50; 35 participants — p=.05
Phase 4 N=30 Effect of Single Dose Intranasal Insulin On Cognitive Function
Schizophrenia · Schizoaffective Disorder
Primary: Improvement in Cognitive Function- HVLT Immediate Recall Total (Number) — 4.9; 5.3 Words successfully recalled
Phase 4 N=340 Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic
Pain
Primary: Mean Pain Intensity Difference at 30 Minutes (mPID30min) — 34.147; 35.266 mm
Phase 4 N=24 Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
Schizophrenia
Primary: Change From Baseline in Fasting Glucose — 5; -4.5 mg/dL — p=0.956
Phase 4 N=15 A Placebo-Controlled, Cross-Over Trial of Aripiprazole
Schizophrenia
Primary: Change From Baseline in Weight (Lbs) — -2.9; 2.1 lbs — p=0.003
Phase 4 N=353 Liver Safety Under Upfront Arimidex vs Tamoxifen
Breast Cancer
Primary: Incidence of Fatty Liver Disease — 9; 53; 15; 66 participants
Phase 4 N=11 Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
Tourette's Syndrome · Tic Disorders
Primary: Calculating Difference Between Means (Baseline and Endpoint Scores on the Yale Global Tic Severity Scale Subscales) — 15.82; 9.73; 12.36; 7.00 units on a scale — p=<.05
Phase 4 N=101 Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
Osteoarthritis, Knee
Primary: Pain( Visual Analog Scale ) — 2.3; 6.4 units on a scale
Phase 4 N=100 Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure
Partial Epilepsies
Primary: Number of Subjects Reporting at Least 1 Treatment-Emergent Adverse Event (TEAE) During the Study — 64 subjects
Phase 4 N=18 Effect of Weight and/or Obesity on Ethambutol Drug Concentrations
Obesity · Tuberculosis
Primary: Total Clearance of Ethambutol — 80.8 L/h
Phase 4 N=292 Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home
Influenza
Primary: Number of Participants Who Received Influenza Vaccine. — 250 participants